AbbVie after earnings, guidance and news: what happened the previous times
Every earnings report, outlook change and other company event Regimic has recorded for AbbVie since 2023 (13 events), each with how the stock moved 1 and 5 sessions later and what happened the previous times. Past reactions, not a probability.
The last 8 times AbbVie received a regulatory approval, the stock was higher 5 sessions later in 3 of them (median move −0.1%, range −2.0% to +2.8%).
The last 4 times AbbVie raised its guidance, the stock was higher 5 sessions later in 2 of them (median move +1.5%, range −1.8% to +7.3%).
Past reactions, not a probability.
Event history
Every event, newest first
“The previous times” are the earlier events of the same type at AbbVie, at least 60 days before, the latest 12. Counts and medians need at least three of them.
No earlier event of this type for AbbVie in the record.
Today’s news, with what happened the previous times
Historical Analogs puts today’s company news and the next scheduled market events next to how the market reacted the previous times. Past reactions, not a probability.
What did AbbVie stock do after it received a regulatory approval?
The last 8 times, it was higher 5 sessions later in 3 of them, with a median move of −0.1% and a range from −2.0% to +2.8%. That describes past reactions, not a probability.
What did AbbVie stock do after it raised its guidance?
The last 4 times, it was higher 5 sessions later in 2 of them, with a median move of +1.5% and a range from −1.8% to +7.3%. That describes past reactions, not a probability.
How are the stock moves measured?
From the first U.S. session open after the news to the close 1 and 5 sessions later, in percent, without dividends or costs. Each move is also shown against the S&P 500 (SPY) and the company’s sector ETF over the same sessions.
Which events are included?
Earnings reports against analysts’ estimates, outlook changes, dividends and buybacks, deals, CEO changes, regulatory decisions, major contracts and new products: company news published on Regimic and verified earlier events. Reports of the same event a few days apart count once; analyst rating changes are not company events.
Does this say what AbbVie stock will do next time?
No. These are past reactions, not a probability: every event is different, and the next reaction can fall outside the past range.
Every company event Regimic published in Company News or verified (earnings calendar, confirmed sources). Events are only added; a wrong one (another company with the same name, or removed by hand) is never shown, and a measured reaction never changes. Reaction: from the first U.S. session open after the news to the close 1 and 5 sessions later, also against SPY and the company's sector ETF. Previous times: earlier events of the same type at the same company, at least 60 days before, the latest 12; counts, median, range and averages need at least three cases. Reports of the same type at the same company within 7 days (30 days for quarterly results) are one event, dated by the first. Past reactions, not a probability. Data updated 02 Nov 2026. For information only; not investment advice. Methodology